Pharmacology Research & Perspectives

Untitled Document
Pharmacology Research & Perspective

Pharmacology Research & Perspectives The Home for Target Validation Papers

What is a Target Validation Paper?

Pharmacology Research & Perspectives (PR&P) has launched an efficient and timely means for researchers to publish clinical findings that show a putative drug target to be invalid.

Historically, such ‘negative’ findings have tended to remain unpublished, leaving others to repeat fruitless investigations. Journal referees often reject papers on the grounds that the findings are negative leaving no record of a study outcome that is actually important, since it allows the sector to focus elsewhere in the pursuit of new medicines. Fortunately, increasingly, disclosure of ‘negative’ findings at the clinical trial end of research is likely to become a requirement in most countries.

Failure in clinical ‘proof-of-concept’ studies is known to be a major factor contributing to high attrition rates in drug development, either from lack of efficacy or side-effects. These failures reflect the fact that preclinical ‘target validation’ studies do not always translate into man, where ultimate target validation must reside. Data from such clinical studies could therefore provide invaluable information on target validation.

Because we recognise that if projects are terminated it may be difficult to justify significant resource to write up the findings for publication, we encourage authors to use any resources that are available to compile a manuscript e.g. information from the Clinical Investigator’s Brochure. When preparing a manuscript we encourage authors to examine whether the findings reflect a failure of the compound, the study design or the molecular target (drug versus design versus concept).

Target Validation Articles Published in PR&P to Date

What Other Special Articles Does PR&P Publish?Pharmacology Research & Perspectives

  • Drug discovery reviews
    Strategy, hypotheses and data resulting in a successful therapeutic drug

  • Frontiers in translational medicine
    Drug and target validation for an unmet therapeutic need

  • Pharmacological hypotheses
    Reviews that are oriented to inform a novel hypothesis

  • Replication studies
    Work that refutes key findings (failed replication), and work that validates key findings

Reasons to Submit

  • Open Access – all articles are freely available immediately on publication
  • High visibility – published on Wiley Online Library and included in PubMed Central
  • Rapid Peer Review – an average of 3 weeks from submission to decision
  • Rapid publication – average time from acceptance to publication 74 days
  • Submissions reviewed by at least 3 referees
  • Fully compliant with all Open Access mandates
  • Authors retain copyright and articles are published under a Creative Commons License
  • Strong international editorial team

About the Journal

Pharmacology Research & Perspectives is published by two of the world’s leading pharmacology societies – the American Society for Pharmacology & Experimental Therapeutics (ASPET) and the British Pharmacological Society (BPS) in partnership with Wiley Open Access.

As part of its continuing commitment to the principles of transparency, BPS is a signatory of the AllTrials campaign which calls for all clinical trials to be registered and their outcomes to be reported.

All articles undergo rapid peer review (a minimum of 3 referees). Publication is ‘gold’ open access (articles immediately and freely available to read, download and share). Publication is fully compliant with all open access mandates, authors retain copyright and articles are published under a Creative Commons License.

To cover the cost of publishing, Pharmacology Research & Perspectives charges a publication fee ($2,500 / £1,625 / €1,900). For members of ASPET or BPS, the publication charge is discounted by 10%. Fee waiver is possible for articles deemed by the editors to be of high importance.

What is Open Access?

Wiley Open Access is a program of fully open access journals.

Discover more about:
Open Access Options
How your institution could pay your open access fees for you
OA Policies by Funder
OA Policies by Country
Self Archiving

What Next?

If you would like to receive more information to decide if Pharmacology Research & Perspectives is the ideal home for your Target Validation article, contact the editorial office for rapid feedback on a pre-submission enquiry.

Submit your article here ▶